Yanmei Xu

5PUBLICATIONS
17CO-AUTHORS
Economic models and forecastingHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 18, 2026
External validation of the AAA+ survival model in a large Chinese cohort with essential thrombocythaemia.

|Oct 21, 2025
Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial.

Yunfei Chen, Yanmei Xu, Jiawen Dai

|Jun 20, 2024
A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia.

Yunfei Chen, Yanmei Xu, Huiyuan Li

|Apr 23, 2024
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.

Yunfei Chen, Yanmei Xu, Ying Chi

Pageof 1

Frequent Collaborators

5 joint publications

Yunfei Chen

4 joint publications

Lei Zhang

3 joint publications

Ting Sun

3 joint publications

Feng Xue